Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery
Urinary Retention Postoperative
About this trial
This is an interventional treatment trial for Urinary Retention Postoperative
Eligibility Criteria
Inclusion Criteria:
- 18 years or older
- willing and able to provide informed consent
- postoperative urinary retention as defined by a failed RGVT prior to hospital discharge
- Ability to speak and read English
- Tolerate pill ingestion
Exclusion Criteria:
- allergy/intolerance to Tamsulosin or sulfa drugs
- preoperative history of urinary retention as defined by preoperative post void residual of >150mL
- current use of alpha antagonist medication for hypertension
- severe dementia
- end stage renal or liver disease
- history of severe heart failure or major cardiovascular event in the last 6 months
Sites / Locations
- West Penn HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Tamsulosin
Placebo
10 capsules will be distributed to subjects to be taken daily. Each capsule contains 0.4mg of Tamsulosin. Subjects will take the capsule once daily until the end of the 10 day course or until the resolution of acute postoperative urinary retention. Both study drug and placebo will appear identical and will be prepared by the pharmacy.
10 capsules will be distributed to subjects to be taken daily. Subjects will take the capsule once daily until the end of the 10 day course or until the resolution of acute postoperative urinary retention. Both study drug and placebo will appear identical and will be prepared by the pharmacy.